{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:06:43Z","timestamp":1787170003402,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Traditional surveillance of adverse infant outcomes following maternal medication exposures relies on pregnancy exposure registries, which are often underpowered. We characterize the statistical power of TreeScan, a data mining tool, to identify potential signals in the setting of perinatal medication exposures and infant outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We used empirical data to inform background incidence of major congenital malformations and other birth conditions. Statistical power was calculated using two probability models compatible with TreeScan, Bernoulli and Poisson, while varying the sample size, magnitude of the risk increase, and incidence of a specified outcome. We also simulated larger referent to exposure matching ratios when using the Bernoulli model in the setting of fixed N:1 propensity score matching. Finally, we assessed the impact of outcome misclassification on power.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The Poisson model demonstrated greater power to detect signals than the Bernoulli model across all scenarios and suggested a sample size of 4,000 exposed pregnancies is needed to detect a twofold increase in risk of a common outcome (approximately 8 per 1,000) with 85% power. Increasing the fixed matching ratio with the Bernoulli model did not reliably increase power. An outcome definition with high sensitivity is expected to have somewhat greater power to detect signals than an outcome definition with high positive predictive value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Use of the Poisson model with an outcome definition that prioritizes sensitivity may be optimal for signal detection. TreeScan is a viable method for surveillance of adverse infant outcomes following maternal medication use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ede.0000000000001561","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T16:01:30Z","timestamp":1666022490000},"page":"90-98","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Monitoring Drug Safety in Pregnancy with Scan Statistics: A Comparison of Two Study Designs"],"prefix":"10.1097","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8989-7878","authenticated-orcid":false,"given":"Elizabeth A.","family":"Suarez","sequence":"first","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[{"name":"Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7814-7625","authenticated-orcid":false,"given":"Danijela","family":"Stojanovic","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9754-1986","authenticated-orcid":false,"given":"Monica","family":"Munoz","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Liedtka","sequence":"additional","affiliation":[{"name":"Division of Pediatric and Maternal Health, Center for Drug and Evaluation Research, US Food and Drug Administration, Silver Spring, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Anderson","sequence":"additional","affiliation":[{"name":"Division of Urology, Obstetrics and Gynecology, Center for Drug and Evaluation Research, US Food and Drug Administration, Silver Spring, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4591-7149","authenticated-orcid":false,"given":"Inna","family":"Dashevsky","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"DeLuccia","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Menzin","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8307-6793","authenticated-orcid":false,"given":"Jennifer","family":"Noble","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9900-2142","authenticated-orcid":false,"given":"Judith C.","family":"Maro","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"R2-20250801","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40264-017-0591-5","article-title":"Enrollment and retention in 34 United States pregnancy registries contrasted with the manufacturer\u2019s capture of spontaneous reports for exposed pregnancies.","volume":"41","author":"Bird","year":"2018","journal-title":"Drug Saf"},{"key":"R3-20250801","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/pds.4150","article-title":"A systematic review of pregnancy exposure registries: examination of protocol-specified pregnancy outcomes, target sample size, and comparator selection.","volume":"26","author":"Gelperin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R4-20250801","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/1541-0420.00039","article-title":"A tree-based scan statistic for database disease surveillance.","volume":"59","author":"Kulldorff","year":"2003","journal-title":"Biometrics"},{"key":"R5-20250801","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/pds.3423","article-title":"Drug safety data mining with a tree-based scan statistic.","volume":"22","author":"Kulldorff","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R6-20250801","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.3547","article-title":"Mini-Sentinel methods: framework for assessment of positive results from signal refinement.","volume":"23","author":"McClure","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R7-20250801","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/EDE.0000000000000907","article-title":"Data mining for adverse drug events with a propensity score-matched tree-based scan statistic.","volume":"29","author":"Wang","year":"2018","journal-title":"Epidemiology"},{"key":"R8-20250801","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/aje\/kwaa288","article-title":"Active surveillance of the safety of medications used in pregnancy.","volume":"190","author":"Huybrechts","year":"2021","journal-title":"AJE"},{"issue":"S2","key":"R9-20250801","first-page":"29","article-title":"A general propensity score for signal detection using tree-based scan statistics.","volume":"28","author":"Wang","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R10-20250801","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/aje\/kwy023","article-title":"Assessment of quadrivalent human papillomavirus vaccine safety using the self-controlled tree-temporal scan statistic signal-detection method in the sentinel system.","volume":"187","author":"Yih","year":"2018","journal-title":"Am J Epidemiol"},{"key":"R11-20250801","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/aje\/kwz104","article-title":"Using the self-controlled tree-temporal scan statistic to assess the safety of live attenuated herpes zoster vaccine.","volume":"188","author":"Yih","year":"2019","journal-title":"Am J Epidemiol"},{"key":"R12-20250801","first-page":";191:957\u2013964","article-title":"A broad safety assessment of the recombinant herpes zoster vaccine.","author":"Yih","year":"2022","journal-title":"Am J Epidemiol"},{"key":"R15-20250801","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/aje\/kwq224","article-title":"Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score.","volume":"172","author":"Austin","year":"2010","journal-title":"Am J Epidemiol"},{"key":"R16-20250801","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jclinepi.2011.09.002","article-title":"Tradeoffs between accuracy measures for electronic health care data algorithms.","volume":"65","author":"Chubak","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"R17-20250801","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/pds.3618","article-title":"Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.","volume":"23","author":"Maro","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R18-20250801","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0272989X09341755","article-title":"The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies.","volume":"29","author":"Austin","year":"2009","journal-title":"Med Decis Making"},{"key":"R19-20250801","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/sim.3780","article-title":"A conditional maximized sequential probability ratio test for Pharmacovigilance.","volume":"29","author":"Li","year":"2010","journal-title":"Stat Med"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:09:15Z","timestamp":1754060955000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001561","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,17]]}}}